Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 26718929

Addition of docetaxel or bisphosphonates to standard of care in men with localised or metastatic, hormone-sensitive prostate cancer: a systematic review and meta-analyses of aggregate data.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Lancet Oncol
Publication date
2016 Feb
First author
Vale CL

This record carries publication-notice metadata. Review the notices below before relying on it.

Publication notices

absence is not clearance
true
has correction metadata
true
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Nat Rev Urol. 2016 Feb;13(2):61. doi: 10.1038/nrurol.2016.4.
    note
    Source null
    related pmid
    26787390
    relationship
    Comment in
  2. citation
    Lancet Oncol. 2016 Feb;17(2):e46. doi: 10.1016/S1470-2045(16)00020-6.
    note
    Source null
    related pmid
    26868352
    relationship
    Erratum in

Authors and identifiers

  1. name
    Vale CL
    type
    Author
  2. name
    Burdett S
    type
    Author
  3. name
    Rydzewska LHM
    type
    Author
  4. name
    Albiges L
    type
    Author
  5. name
    Clarke NW
    type
    Author
  6. name
    Fisher D
    type
    Author
  7. name
    Fizazi K
    type
    Author
  8. name
    Gravis G
    type
    Author
  9. name
    James ND
    type
    Author
  10. name
    Mason MD
    type
    Author
  11. name
    Parmar MKB
    type
    Author
  12. name
    Sweeney CJ
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Vale CL
    type
    Author
  2. name
    Burdett S
    type
    Author
  3. name
    Rydzewska LHM
    type
    Author
  4. name
    Albiges L
    type
    Author
  5. name
    Clarke NW
    type
    Author
  6. name
    Fisher D
    type
    Author
  7. name
    Fizazi K
    type
    Author
  8. name
    Gravis G
    type
    Author
  9. name
    James ND
    type
    Author
  10. name
    Mason MD
    type
    Author
  11. name
    Parmar MKB
    type
    Author
  12. name
    Sweeney CJ
    type
    Author
bibliography ids
  1. nci-bib-8dde89d74ef101deee9de9c4
book metadata
content sha256
00818126350181287e637127642d4d2a8f50af74f1932e05b36c3805ab7d316f
document type
citation
dois
  1. 10.1016/S1470-2045(15)00489-1
electronic publication date
display
2015 Dec 21
precision
day
year
2015
evidence scope
bibliographic_metadata_only
id
pubmed:26718929
immutable id
pubmed:26718929@00818126350181287e637127642d4d2a8f50af74f1932e05b36c3805ab7d316f
journal
abbreviation
Lancet Oncol
issn electronic
1474-5488
issn print
1470-2045
issue
2
name
The Lancet. Oncology
nlm unique id
100957246
pages
243-256
volume
17
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
true
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Nat Rev Urol. 2016 Feb;13(2):61. doi: 10.1038/nrurol.2016.4.
    note
    Source null
    related pmid
    26787390
    relationship
    Comment in
  2. citation
    Lancet Oncol. 2016 Feb;17(2):e46. doi: 10.1016/S1470-2045(16)00020-6.
    note
    Source null
    related pmid
    26868352
    relationship
    Erratum in
outcomes validated
false
pmid
26718929
provenance
batch id
948d34b0dea86780a31d
provider
NCBI PubMed ESummary
record sha256
a7a86aaecde1ed894ad2b08126cb0a5da5b10a6676815569b70ec4004fb29dca
response sha256
11c34185eb9e4ea0d3c4d255d31806495349b0f097d492c4e135946541bf4bb5
retrieved at
2026-09-09T23:47:15.495091+00:00
publication date
display
2016 Feb
precision
month
year
2016
publication types
  1. Journal Article
  2. Meta-Analysis
  3. Research Support, Non-U.S. Gov't
  4. Systematic Review
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/26718929/
title
Addition of docetaxel or bisphosphonates to standard of care in men with localised or metastatic, hormone-sensitive prostate cancer: a systematic review and meta-analyses of aggregate data.

Preserved source evidence · Not medical advice